Literature DB >> 10669125

Prevalence of bacterial vaginosis and correlation of clinical to Gram stain diagnostic criteria in low risk pregnant women.

E Gratacós1, F Figueras, M Barranco, R Ros, A Andreu, P L Alonso, V Cararach.   

Abstract

The present study aimed to evaluate the prevalence of bacterial vaginosis, and the correlation of clinical Amsel criteria with Gram Nugent criteria for the diagnosis of bacterial vaginosis in a low risk population of pregnant women. Pregnant women under 28 weeks of gestation who were followed in the low risk clinics at two centers were evaluated for the presence of bacterial vaginosis using the Amsel clinical criteria, and underwent vaginal samples for Gram staining. Gram smears were examined for the diagnosis of bacterial vaginosis on the basis of Nugent's criteria. A total of 492 women were included in the study. Bacterial vaginosis was diagnosed in 1.6% (8/492) women on the basis of clinical criteria, and in 4.5% (22/492) according to Gram stain. The sensitivity and specificity of Amsel criteria compared with Gram stain were 35% and 99%, respectively. In accordance with other recent reports, the prevalence of bacterial vaginosis appears to be much lower in certain areas than figures previously suggested. In these populations, the correlation of composite clinical criteria defined in groups with high prevalence of bacterial vaginosis appears to be also poor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10669125     DOI: 10.1023/a:1007673531595

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  22 in total

Review 1.  Bacterial vaginosis: a diagnostic approach.

Authors:  C S Easmon; P E Hay; C A Ison
Journal:  Genitourin Med       Date:  1992-04

2.  Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis.

Authors:  J R Schwebke; S L Hillier; J D Sobel; J A McGregor; R L Sweet
Journal:  Obstet Gynecol       Date:  1996-10       Impact factor: 7.661

3.  Statistical evaluation of diagnostic criteria for bacterial vaginosis.

Authors:  J L Thomason; S M Gelbart; R J Anderson; A K Walt; P J Osypowski; F F Broekhuizen
Journal:  Am J Obstet Gynecol       Date:  1990-01       Impact factor: 8.661

4.  [Prevalence of bacterial vaginosis in an obstetric population of Barcelona].

Authors:  B Martínez de Tejada; O Coll; M de Flores; S L Hillier; D V Landers
Journal:  Med Clin (Barc)       Date:  1998-02-21       Impact factor: 1.725

5.  Association of bacterial vaginosis with a history of second trimester miscarriage.

Authors:  J M Llahi-Camp; R Rai; C Ison; L Regan; D Taylor-Robinson
Journal:  Hum Reprod       Date:  1996-07       Impact factor: 6.918

6.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

7.  Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial.

Authors:  H M McDonald; J A O'Loughlin; R Vigneswaran; P T Jolley; J A Harvey; A Bof; P J McDonald
Journal:  Br J Obstet Gynaecol       Date:  1997-12

8.  Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.

Authors:  R Amsel; P A Totten; C A Spiegel; K C Chen; D Eschenbach; K K Holmes
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

9.  Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid.

Authors:  C A Spiegel; R Amsel; K K Holmes
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

10.  Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group.

Authors:  S L Hillier; R P Nugent; D A Eschenbach; M A Krohn; R S Gibbs; D H Martin; M F Cotch; R Edelman; J G Pastorek; A V Rao
Journal:  N Engl J Med       Date:  1995-12-28       Impact factor: 91.245

View more
  7 in total

1.  Quantitative gram stain interpretation criteria used by microbiology laboratories in Alberta, Canada.

Authors:  D Church; E Melnyk; B Unger
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

2.  Bacterial vaginosis: not a risk factor for preterm birth?

Authors:  Hans Verstraelen; Stijn Vansteelandt; Marleen Temmerman
Journal:  Br J Gen Pract       Date:  2004-07       Impact factor: 5.386

3.  Use of vaginal pH in diagnosis of infections and its association with reproductive manifestations.

Authors:  Jayanti Mania-Pramanik; S C Kerkar; P B Mehta; S Potdar; V S Salvi
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

4.  Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women.

Authors:  Beverly E Sha; Hua Y Chen; Qiong J Wang; M Reza Zariffard; Mardge H Cohen; Gregory T Spear
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Comparison of clinical and gram stain diagnosis methods of bacterial vaginosis among pregnant women in ethiopia.

Authors:  Zemenu Mengistie; Yimtubezinash Woldeamanuel; Daniel Asrat; Mahlet Yigeremu
Journal:  J Clin Diagn Res       Date:  2013-12-15

6.  Prevalence of bacterial vaginosis in Portuguese pregnant women and vaginal colonization by Gardnerella vaginalis.

Authors:  Daniela Machado; Joana Castro; José Martinez-de-Oliveira; Cristina Nogueira-Silva; Nuno Cerca
Journal:  PeerJ       Date:  2017-08-29       Impact factor: 2.984

7.  Basic vaginal pH, bacterial vaginosis and aerobic vaginitis: prevalence in early pregnancy and risk of spontaneous preterm delivery, a prospective study in a low socioeconomic and multiethnic South American population.

Authors:  Leticia Krauss-Silva; Antonio Almada-Horta; Mariane B Alves; Karla G Camacho; Maria Elizabeth L Moreira; Alcione Braga
Journal:  BMC Pregnancy Childbirth       Date:  2014-03-19       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.